24 Jun 2022 --- This week in nutrition news, Balchem completed its acquisition of Kappa Bioscience for a value of NOK 3.175 billion (US$338 million). Lallemand Health Solutions inaugurated a new probiotic bacteria production plant. Meanwhile, Kyowa Hakko Bio’s 2'-Fucosyllactose human milk oligosaccharide (HMO) passed China’s safety evaluation.